Status:
COMPLETED
Tolerance of Infants With Cow's Milk Protein Allergy to Extensively Hydrolyzed Rice Protein or Casein Infant Formulas
Lead Sponsor:
Lactalis
Collaborating Sponsors:
Biosearch S.A.
Conditions:
Cow Milk Protein Sensitivity
Tolerance
Eligibility:
All Genders
Up to 9 years
Phase:
PHASE2
Brief Summary
The objective of this double blinded randomized study is to assess the tolerance of two extensively protein hydrolyzed infant formulas, one based on rice protein and the other one on casein, at introd...
Eligibility Criteria
Inclusion
- Full term healthy newborns (37-42 Weeks gestation)
- Weight at birth ≥ 2500 g
- Aged between birth to 9 months
- Symptoms of allergy (Skin or digetive)
- Suspicion of cow milk protein allergy
- Infants whose parents/caregivers/legal guardians have the ability to understand and comply with the requirements of the study
- Infants whose parents/caregivers/legal guardians gave their written informed consent to the infant's participation in the study
Exclusion
- Children who have returned to breastfeeding
- Presence of any condition, that, in the opinion of the investigator is a contra-indication to the particpation of the infant in the study
- In the past 15 days, treatment or medication likely to :
- induce confusion in the allergy tets (ex. : Skin Prick Test) and / or
- mask the symptoms of an allergic reaction (Anti-allergy medications ; anti-histaminic, anti-leucotrienes, corticosteroids, …)
- Newbonrs presenting a chronic or a genetic malformation, or a chromosomal or other disease, that in the opinion of the investigator could mask the study results
- Children who show signs of malnutrition, or prolonged diarrhea
- Children whose parents show no willingness to comply with study requirements
- Consumption of soya protein based, hydrolyzed protein or elemental (amino acid) formula for more than 21 days before inclusion, unless the skin prick test to cow's milk protein is positive, and the IgE level indicates the existence of IgE mediated allergy to cow's milk protein.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT01909661
Start Date
March 1 2013
End Date
August 1 2014
Last Update
April 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biosearch S.A.
Granada, Spain, 18004